The current price of 6869.T is ¥2,017.00 — it has increased by 3.70% since the previous close. Data as of Nov 5, 2026.
6869.T is up 5.13% over the past week, up 10.13% over the past month and up 18.16% over the past year. The price is above its 200-day moving average of ¥1,581.54.
Of the 14 analysts covering Sysmex Corporation, 3 rate it a strong buy, 5 rate it a buy and 6 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Sysmex Corporation has a market capitalization of ¥1.21T. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Sysmex Corporation posted earnings of ¥14.17 per share against an estimate of ¥9.00, beating expectations by 57.44%. Upcoming reports are listed in the earnings calendar.
Sysmex Corporation reported revenue of ¥130.67B in its most recent quarter, which has increased by 23.59% compared with the same quarter a year earlier. Analysts had expected ¥117.18B.
Yes. Sysmex Corporation pays dividends semi-annually. The latest payment of ¥20.00 per share has a payment date of Mar 30, 2027, which corresponds to a dividend yield of 1.98%.
Companies most comparable to Sysmex Corporation include HORIBA, Ltd., JEOL Ltd., Ship Healthcare Holdings, Inc., H.U. Group Holdings, Inc. and PHC Holdings Corporation.
In the latest trading session 6869.T moved between ¥1,994.00 and ¥2,028.00, a range of 1.69% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Sysmex Corporation shows a strong buy rating today and a buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks 6869.T has traded between ¥1,246.00 and ¥2,028.00. The current price is 0.54% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.